동향
동향 내용
Emergency Investigational New Drug (EIND) Applications for Antiviral Products
분류 Investigational New drug application 조회 2409
발행년도 2014 등록일 2015-07-27
출처 FDA (바로가기)
The following information is to be used by physicians who would like to request an Emergency IND for an antiviral product regulated by the Center for Drug Evaluation and Research (CDER)/Division of Antiviral Products (DAVP). Emergency IND requests for products not regulated by CDER/DAVP should be directed to the appropriate point of contact for the FDA Center/Division in which the product is reviewed.

목록



[추천 메일 발송]
추천 메일 발송
받는 분 이메일 @
추천인
리스트 이전글과 다음글
이전글이전글 CDER New Drug Review
다음글다음글 Guidance Investigational New Drug Application for Positron Emission Tomography (PET) Drugs